Skip to content

Solventum SOLV Loss Contingency Accrual

Loss Contingency Accrual at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
Boston Scientific logo
Boston ScientificBSX
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$2.0B-3.0%
Gross profit$1.1B-1.5%
Operating income$81.0M-46.7%
Net income$13.0M-90.5%
EPS (diluted)$0.07-91.0%

Balance sheet

See full
Cash & equivalents$561.0M+5.1%
Total debt$5.8B-26.8%
Total equity$5.0B+52.3%
Total assets$14.1B-3.0%

Cash flow

See full
Operating cash flow-$189.0M-752%
CapEx$84.0M-22.9%
Free cash flow-$273.0M-241%

Valuation

See full
Market cap$13.06B-13.9%
Enterprise value$18.29B-19.4%
P/E9.1×-30.9×
P/S1.6×-0.2×

Profitability

See full
Gross margin53.7%-0.9pp
Operating margin25.5%+15.8pp
Net margin17.3%+12.8pp
FCF margin4.6%-13.9pp

Returns & leverage

See full
Return on equity34.8%+24.1pp
Debt / equity1.2×-1.3×
Current ratio1.1×-0.1×

Where this comes from

Reported directly by Solventum in its filing.

Tagged under the XBRL concept us-gaap:LossContingencyAccrualAtCarryingValue.

The official record: Solventum’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solventum's loss contingency accrual.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Solventum's loss contingency accrual?
Solventum (SOLV) reported loss contingency accrual of $31M in Q1 2026.
How has Solventum's loss contingency accrual changed year-over-year?
Solventum's loss contingency accrual decreased by 11.4% year-over-year, from $35M to $31M.
What is the long-term trend for Solventum's loss contingency accrual?
Over 2 years (2023 to 2025), Solventum's loss contingency accrual has grown at a 16.1% compound annual growth rate (CAGR), from $23M to $31M.